KDR and neoplasm: The activation of FGFR signaling in cancer cells might also provide direct and/or indirect (e.g. vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor receptor (PDGFR)-mediated) pro-angiogenic effects, thus facilitating tumor development, disease progression, and drug resistance.